Seven Grand Managers’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPR
ACA
Seven Grand Managers's JSPR Position: Q3 2026 in Review
Seven Grand Managers opened a new position in Jasper Therapeutics (JSPR) in Q3 2026: 2,351 shares worth $2M. The stake represents 0.07% of the portfolio and ranks #118 among its holdings.
36 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.
- Seven Grand Managers held 2,351 shares of Jasper Therapeutics worth $2M as of Q3 2026.
- Jasper Therapeutics was a new Seven Grand Managers position in Q3 2026.
- Jasper Therapeutics made up 0.07% of Seven Grand Managers's portfolio in Q3 2026, its #118 holding.
- 36 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.
Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.